Abstract
Bacterial genetic properties can be readily altered by a range of techniques, for example, when a mixture of recipient bacteria, donor genes, and nano-sized acicular material are stimulated by sliding friction on surface of the hydrogel such as agarose or gellan gum. In this particular case, a phenomenon called the Yoshida effect is responsible. Specially designed apparatus has been developed to investigate this effect in an effort to identify technical applications, such as the quantitative detection of asbestos. Current patents related to plasmid transformation methods for prokaryotes and quantitative detection of environmental asbestos are also presented.
Keywords: Yoshida effect, asbestos, chrysotile, hydrogel, sepiolite, plasmid, prokaryote, sliding friction, transformation
Recent Patents on Biotechnology
Title: Discovery and Application of the Yoshida Effect: Nano-Sized Acicular Materials Enable Penetration of Bacterial Cells by Sliding Friction Force
Volume: 1 Issue: 3
Author(s): Naoto Yoshida
Affiliation:
Keywords: Yoshida effect, asbestos, chrysotile, hydrogel, sepiolite, plasmid, prokaryote, sliding friction, transformation
Abstract: Bacterial genetic properties can be readily altered by a range of techniques, for example, when a mixture of recipient bacteria, donor genes, and nano-sized acicular material are stimulated by sliding friction on surface of the hydrogel such as agarose or gellan gum. In this particular case, a phenomenon called the Yoshida effect is responsible. Specially designed apparatus has been developed to investigate this effect in an effort to identify technical applications, such as the quantitative detection of asbestos. Current patents related to plasmid transformation methods for prokaryotes and quantitative detection of environmental asbestos are also presented.
Export Options
About this article
Cite this article as:
Yoshida Naoto, Discovery and Application of the Yoshida Effect: Nano-Sized Acicular Materials Enable Penetration of Bacterial Cells by Sliding Friction Force, Recent Patents on Biotechnology 2007; 1 (3) . https://dx.doi.org/10.2174/187220807782330147
DOI https://dx.doi.org/10.2174/187220807782330147 |
Print ISSN 1872-2083 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4012 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
MDA-7/IL-24-Based Cancer Gene Therapy: Translation from the Laboratory to the Clinic
Current Gene Therapy Hypoxia and Inflammation in Prostate Cancer Progression. Cross-talk with Androgen and Estrogen Receptors and Cancer Stem Cells
Endocrine, Metabolic & Immune Disorders - Drug Targets A Better Platinum-Based Anticancer Drug Yet to Come?
Anti-Cancer Agents in Medicinal Chemistry HtrA Protease Family as Therapeutic Targets
Current Pharmaceutical Design Vascular Injury During Elevated Glucose can be Mitigated by Erythropoietin and Wnt Signaling
Current Neurovascular Research Survival Benefit of Adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the Different Time-points of Treatment of Ovarian Cancer: Review of Evidence
Current Pharmaceutical Design Chimeric Antigen Receptor T Cells: Self-Replicating Drugs for Cancer
Current Drug Targets Regulation of MET Receptor Signaling by SOCS1 and its Implications for Hepatocellular Carcinoma
Current Pharmaceutical Design Revisiting Non-Cancer Drugs for Cancer Therapy
Current Topics in Medicinal Chemistry The Role of YY1 in Oncogenesis and Its Potential as a Drug Target in Cancer Therapies
Current Cancer Drug Targets Metal Oxide Nanomaterials in Nanomedicine: Applications in Photodynamic Therapy and Potential Toxicity
Current Topics in Medicinal Chemistry Cancer Gene Therapy by Adenovirus-Mediated Gene Transfer
Current Gene Therapy Recent Advancements in Carbon Nanofiber and Carbon Nanotube Applications in Drug Delivery and Tissue Engineering
Current Pharmaceutical Design Radioimmunotherapy of Solid Tumors: Searching for the Right Target
Current Drug Delivery microRNAs in Cancer: Lessons from Melanoma
Current Pharmaceutical Design Pathway of Inflammation due to Asbestiform Fiber “Fluoro-edenite” Exposure: An Update
Current Respiratory Medicine Reviews Dasatinib: An Anti-Tumour Agent via Src Inhibition
Current Drug Targets Patents on Immunotoxins and Chimeric Toxins for the Treatment of Cancer
Recent Patents on Drug Delivery & Formulation Targeting Mitochondria in Fighting Cancer
Current Pharmaceutical Design Recent Development and Application of Magnetic Nanoparticles for Cell Labeling and Imaging
Mini-Reviews in Medicinal Chemistry